CIK细胞在肿瘤过继细胞治疗中的疗效评价 |
| |
引用本文: | 王文浩,李贵新,刘锦. CIK细胞在肿瘤过继细胞治疗中的疗效评价[J]. 国际肿瘤学杂志, 2013, 40(2): 106-108 |
| |
作者姓名: | 王文浩 李贵新 刘锦 |
| |
作者单位: | 王文浩 (261053,潍坊医学院); 李贵新 (261053,潍坊医学院肿瘤学教研室); 刘锦 (261053,潍坊医学院肿瘤学教研室); |
| |
摘 要: |
|
Assessment of CIK cells in adoptive cellular therapy |
| |
Affiliation: | Weifang Medical University, Weifang 261053, China |
| |
Abstract: | Cytokine-induced killer (CIK) cells therapy plays an important role in cancer adjuvant treatment. Researches show that the number of peripheral blood immunocytes will change if patients with cancer accept the treatment of CIK cells. The changes of T cell subsets, regulatory T cells are relatively obvious, which may be one of the standards that can evaluate the curative effect of CIK cells. |
| |
Keywords: | Neoplasms Cytokine-induced killer cells Immune response |
|
| 点击此处可从《国际肿瘤学杂志》浏览原始摘要信息 |
|
点击此处可从《国际肿瘤学杂志》下载全文 |
|